CAREDX, INC.— Sankey Diagram
Quarterly mode · period ending 2026-03-31 · SEC EDGAR
ComparingFY2026 (Q4) vs FY2025 (Q4)
Revenue
$118M
↑+39.0% +$33Mvs FY2025 (Q4)
Gross Profit
$118M
↑+39.0% +$33Mvs FY2025 (Q4)
Operating Income
$1M
↓-98.1% -$61Mvs FY2025 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 (Q4) | FY2025 (Q4) |
|---|---|---|
| Revenue | $118M | $85M |
| COGS | $0 | $0 |
| Gross Profit | $118M | $85M |
| R&D | $21M | $19M |
| SG&A | $0 | $0 |
| D&A | $4M | $4M |
| Other OpEx | $91M | $295K |
| Operating Income | $1M | $62M |
| Interest Exp. | $1M | $3M |
| Other Non-Op | $0 | $59M |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · CDNA · Comparing FY2026 (Q4) vs FY2025 (Q4)